Floatz logo

IMMUNE GLOBULIN INTRAVENOUS (HUMAN)

Alzheimer´s Disease

Baxalta now part of Shireother_biologicalPhase 3Dormant
CC
45/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
30/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Alzheimer´s Disease cohort.

Asset / SponsorPhaseRating
HUMAN IMMUNOGLOBULINS
Baxalta now part of Shire
Phase 3BB
NORMAL HUMAN SERUM ALBUMIN
Baxalta now part of Shire
Phase 3B
azd1446
AstraZeneca
Phase 2CCC
Lornoxicam
JSW Lifesciences
Phase 2CCC
Affitope® Ad02
Affiris AG
Phase 2CCC
(11C)AZD2995
AstraZeneca
Phase 1CC

Same molecule, other indications

IMMUNE GLOBULIN INTRAVENOUS (HUMAN) is also rated in:

Post-polio SyndromeDormant
CC
Indicative ·
41 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →